Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing

被引：32

作者：

Wong, RCW ^{[1
]}

Adelstein, S

Gillis, D

Favaloro, EJ

机构：

[1] Princess Alexandra Hosp, Queensland Hlth Pathol Serv, Div Immunol, Woolloongabba, Qld 4102, Australia

[2] Royal Brisbane Hosp, Brisbane, Qld 4029, Australia

[3] Royal Prince Alfred Hosp, Dept Clin Immunol, Cent Sydney Lab Serv, Sydney, NSW, Australia

[4] Westmead Hosp, Haemostasis Labs, Dept Hematol, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2005年 / 31卷 / 01期

关键词：

cardiolipin; consensus guidelines; lupus anticoagulant; recommendation; standardization;

D O I：

10.1055/s-2005-863804

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Interlaboratory and intermethod variation in commercial and in-house tests used for the measurement of anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) limit the diagnostic value of the results from these tests. This short review summarizes published and unpublished guidelines (some developed using consensus procedures) on aCL and LA testing that are aimed at decreasing assay variation.

引用

页码：39 / 48

页数：10

共 45 条

[1] FALSE-POSITIVE TEST RESULT FOR IGM ANTICARDIOLIPIN ANTIBODY DUE TO IGM RHEUMATOID-FACTOR [J].